Eversept Partners, LP Coherus Bio Sciences, Inc. Transaction History

Eversept Partners, LP

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2019 Aug 13, 2019	SELL	$13.1 - $22.1 $1.57 Million - $2.65 Million	-120,036 Closed	0 $0
Q1 2019 Nov 08, 2023	BUY	$8.38 - $15.5 $1.01 Million - $1.86 Million	120,036 New	120,036 $1.64 Million
Q1 2019 May 14, 2019	BUY	$8.38 - $15.5 $1.01 Million - $1.86 Million	120,036 New	120,036 $1.64 Million

133

76.9M

40.7K

50.1K

Ticker CHRS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 77,724,600
Market Cap $91.7M
Description
Coherus BioSciences, Inc., a biopharmaceutical company, focuses on the biosimilar and immuno-oncology market primarily in the United States. The company markets UDENYCA, a biosimilar to Neulasta, a long-acting granulocyte stimulating colony factor in the United States. Its pipeline products include biosimilars of Humira, Avastin, and Lucentis. T...

Get notified when there are updates to the investment portfolio of Eversept Partners, LP, based on Form 13F filings with the SEC.

Stay updated on Eversept Partners, LP with notifications on news.